We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPHR
2276
DELISTED
Cipher Pharmaceuticals Inc.
CPHR
$8K ﹤0.01%
2,100
+990
+89% +$4.51K
PVCT
2277
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$8K ﹤0.01%
81,647
+54,196
+197% +$11.8K
GIG
2278
DELISTED
GigPeak, Inc.
GIG
$8K ﹤0.01%
+3,383
New +$6.99K
ATV
2279
DELISTED
Acorn International
ATV
$8K ﹤0.01%
740
IBTX
2280
DELISTED
Independent Bank Group, Inc.
IBTX
$8K ﹤0.01%
+181
New +$7.78K
CIZN
2281
DELISTED
Citizens Holding Co.
CIZN
$8K ﹤0.01%
356
+51
+17% +$1.16K
NTP
2282
DELISTED
Nam Tai Property Inc.
NTP
$8K ﹤0.01%
+1,015
New +$7.02K
SGB
2283
DELISTED
Southwest Georgia Financial Corporation
SGB
$8K ﹤0.01%
471
+120
+34% +$1.84K
IPAS
2284
DELISTED
Ipass Inc Common Stock
IPAS
$8K ﹤0.01%
514
+339
+194% +$5.08K
FFBCW
2285
DELISTED
First Financial Bancorp. Warrant
FFBCW
$8K ﹤0.01%
816
SGY
2286
DELISTED
Stone Energy
SGY
$8K ﹤0.01%
122
-23
-16% -$1.66K
TNH
2287
DELISTED
Terra Nitrogen
TNH
$8K ﹤0.01%
75
-49
-40% -$5.49K
OKSB
2288
DELISTED
Southwest Bancorp Inc/OK
OKSB
$8K ﹤0.01%
400
+309
+340% +$5.82K
NWBO
2289
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$8K ﹤0.01%
15,504
-5,891
-28% -$2.69K
AKTX
2290
Akari Therapeutics
AKTX
$12.3M
$7K ﹤0.01%
+1
New +$7.8K
AMSC icon
2291
American Superconductor
AMSC
$1.59B
$7K ﹤0.01%
+1,131
New +$8.77K
AROW icon
2292
Arrow Financial
AROW
$652M
$7K ﹤0.01%
245
-425
-63% -$10.8K
ARTNA icon
2293
Artesian Resources
ARTNA
$358M
$7K ﹤0.01%
249
+71
+40% +$2.18K
ASRT
2294
DELISTED
Assertio
ASRT
$7K ﹤0.01%
5
-55
-92% -$69.1K
ASYS icon
2295
Amtech Systems
ASYS
$272M
$7K ﹤0.01%
1,508
-4,803
-76% -$26.5K
ATEX icon
2296
Anterix
ATEX
$1.94B
$7K ﹤0.01%
307
+296
+2,691% +$6.61K
ATXS
2297
DELISTED
Astria Therapeutics
ATXS
$7K ﹤0.01%
+20
New +$5.27K
BHK icon
2298
BlackRock Core Bond Trust
BHK
$667M
$7K ﹤0.01%
500
-200
-29% -$2.82K
BOTJ icon
2299
Bank Of The James
BOTJ
$124M
$7K ﹤0.01%
651
-137
-17% -$1.57K
CPIX icon
2300
Cumberland Pharmaceuticals
CPIX
$117M
$7K ﹤0.01%
1,314
+1,214
+1,214% +$5.71K

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.